DBRS Morningstar Releases Commentary on Risk Exposure of European ABS to COVID-19

DBRS Morningstar released a commentary titled “European ABS Transactions' Risk Exposure to Coronavirus (COVID-19) Effect”.

As the Coronavirus Disease (COVID-19) continues to spread, consumers and businesses are undergoing extraordinary pressure. Although it is hard to anticipate the ultimate impact on the variables that drive credit performance, based on DBRS Morningstar’s latest global macroeconomic scenarios, adverse effects are expected to manifest for many industries, including European consumer and commercial lending.

This commentary outlines the considerations for European ABS transactions rated by DBRS Morningstar. For more details, please read “European ABS Transactions' Risk Exposure to Coronavirus (COVID-19) Effect” available at www.dbrsmorningstar.com.

Notes:
The commentary is available at www.dbrsmorningstar.com.

For more information, visit www.dbrsmorningstar.com or contact us at info@dbrsmorningstar.com.

DBRS Ratings Limited
20 Fenchurch Street, 31st Floor, London EC3M 3BY United Kingdom
Tel. +44(0) 20 7855 6600
Registered and incorporated under the laws of England and Wales: Company No. 7139960